These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 19020723

  • 1. Evaluation of cytotoxic effects induced by bcl-2 and bcl-xL antisense-oligodeoxynucleotides in normal urothelium and transitional cell carcinoma.
    Gabriel U, Bolenz C, Becker A, Schaaf A, Steidler A, Trojan L, Weiss C, Michel MS.
    Oncol Rep; 2008 Dec; 20(6):1419-23. PubMed ID: 19020723
    [Abstract] [Full Text] [Related]

  • 2. Expression of bcl-2 and bcl-X in bladder cancer.
    Kirsh EJ, Baunoch DA, Stadler WM.
    J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882
    [Abstract] [Full Text] [Related]

  • 3. Chemosensitization of bladder carcinoma cells by bcl-xL antisense oligonucleotides.
    Lebedeva I, Raffo A, Rando R, Ojwang J, Cossum P, Stein CA.
    J Urol; 2001 Aug; 166(2):461-9. PubMed ID: 11458048
    [Abstract] [Full Text] [Related]

  • 4. [Effect of phosphorothioate antisense Bcl-xL oligodeoxynucleotides on apoptosis and thermosensitivity of BcaCD885 cells].
    He YW, Bian L, Liang XH.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):112-4. PubMed ID: 15190790
    [Abstract] [Full Text] [Related]

  • 5. Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides.
    Bolenz C, Becker A, Trojan L, Schaaf A, Cao Y, Weiss C, Alken P, Michel MS.
    Urol Oncol; 2007 Apr; 25(6):476-82. PubMed ID: 18047955
    [Abstract] [Full Text] [Related]

  • 6. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.
    Masui T, Hosotani R, Ito D, Kami K, Koizumi M, Mori T, Toyoda E, Nakajima S, Miyamoto Y, Fujimoto K, Doi R.
    Surgery; 2006 Aug; 140(2):149-60. PubMed ID: 16904964
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ, Schrader AJ, Simon C, Dalpke A, Barth P, Hofmann R, Hegele A.
    Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
    [Abstract] [Full Text] [Related]

  • 8. [The effects of antisense oligonucleotides bcl-2/bcl-xl and bcl-2 on proliferation and apoptosis of breast cancer cells].
    Ma C, Xie JW, Kuang AR, Huang R, Tang GS.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):780-3. PubMed ID: 19950582
    [Abstract] [Full Text] [Related]

  • 9. Chemosensitization of breast carcinoma cells with the use of bcl-2 antisense oligodeoxynucleotide.
    Yang JH, Feng F, Qian H, Cheng H.
    Breast; 2004 Jun; 13(3):227-31. PubMed ID: 15177426
    [Abstract] [Full Text] [Related]

  • 10. [Inhibitory effects of bcl-xl antisense oligodeoxynucleotides on growth of human nasopharyngeal carcinoma in nude mice].
    Min L, Zhou KY, Liang T, Zhang YF.
    Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):14-7. PubMed ID: 15059344
    [Abstract] [Full Text] [Related]

  • 11. The effect of antisense Bcl-2 oligonucleotides on Bcl-2 protein expression and apoptosis in human bladder transitional cell carcinoma.
    Duggan BJ, Maxwell P, Kelly JD, Canning P, Anderson NH, Keane PF, Johnston SR, Williamson KE.
    J Urol; 2001 Sep; 166(3):1098-105. PubMed ID: 11490306
    [Abstract] [Full Text] [Related]

  • 12. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
    Jahrsdörfer B, Jox R, Mühlenhoff L, Tschoep K, Krug A, Rothenfusser S, Meinhardt G, Emmerich B, Endres S, Hartmann G.
    J Leukoc Biol; 2002 Jul; 72(1):83-92. PubMed ID: 12101266
    [Abstract] [Full Text] [Related]

  • 13. Expression of chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) in bladder transitional cell carcinoma.
    Ham WS, Lee JH, Yu HS, Choi YD.
    Urology; 2008 Oct; 72(4):921-6. PubMed ID: 18387660
    [Abstract] [Full Text] [Related]

  • 14. Translational studies of glutathione in bladder cancer cell lines and human specimens.
    Pendyala L, Velagapudi S, Toth K, Zdanowicz J, Glaves D, Slocum H, Perez R, Huben R, Creaven PJ, Raghavan D.
    Clin Cancer Res; 1997 May; 3(5):793-8. PubMed ID: 9815751
    [Abstract] [Full Text] [Related]

  • 15. Response of bladder carcinoma cells to TRAIL and antisense oligonucleotide, Bcl-2 or clusterin treatments.
    Sun B, Moibi JA, Mak A, Xiao Z, Roa W, Moore RB.
    J Urol; 2009 Mar; 181(3):1361-71. PubMed ID: 19157446
    [Abstract] [Full Text] [Related]

  • 16. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
    Caprodossi S, Lucciarini R, Amantini C, Nabissi M, Canesin G, Ballarini P, Di Spilimbergo A, Cardarelli MA, Servi L, Mammana G, Santoni G.
    Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
    [Abstract] [Full Text] [Related]

  • 17. Cellular uptake and ex vivo urothelial penetration by oligodeoxynucleotides for optimizing treatment of transitional cell carcinoma.
    Bolenz C, Trojan L, Gabriel U, Honeck P, Wendt-Nordahl G, Schaaf A, Alken P, Michel MS.
    Anal Quant Cytol Histol; 2008 Oct; 30(5):265-73. PubMed ID: 18980158
    [Abstract] [Full Text] [Related]

  • 18. [Bcl-XL antisense oligodeoxynucleotide sensitizes human esophageal cancer cell line to 5-fluorouracil].
    Zhang L, Wen HT, Wang LX, Zhang L, Zhang YH.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):173-7. PubMed ID: 16875599
    [Abstract] [Full Text] [Related]

  • 19. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G, Scarsella M, Semple SC, Mottolese M, Natali PG, Leonetti C.
    Clin Cancer Res; 2005 Mar 01; 11(5):1990-8. PubMed ID: 15756025
    [Abstract] [Full Text] [Related]

  • 20. Effect of antineoplastic drugs on the expression of Bcl-2 and Bcl-xL genes in the feline T-cell leukemia cell line.
    Sano J, Nagafuchi S, Yamazaki J, Oguma K, Kano R, Hasegawa A.
    Res Vet Sci; 2005 Dec 01; 79(3):197-201. PubMed ID: 15893350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.